Tong Yaojun, Charusanti Pep, Zhang Lixin, Weber Tilmann, Lee Sang Yup
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark , Kogle Alle 6, Hørsholm 2970, Denmark.
Department of Bioengineering, University of California, San Diego , La Jolla, California 92093, United States.
ACS Synth Biol. 2015 Sep 18;4(9):1020-9. doi: 10.1021/acssynbio.5b00038. Epub 2015 Apr 7.
Bacteria of the order Actinomycetales are one of the most important sources of pharmacologically active and industrially relevant secondary metabolites. Unfortunately, many of them are still recalcitrant to genetic manipulation, which is a bottleneck for systematic metabolic engineering. To facilitate the genetic manipulation of actinomycetes, we developed a highly efficient CRISPR-Cas9 system to delete gene(s) or gene cluster(s), implement precise gene replacements, and reversibly control gene expression in actinomycetes. We demonstrate our system by targeting two genes, actIORF1 (SCO5087) and actVB (SCO5092), from the actinorhodin biosynthetic gene cluster in Streptomyces coelicolor A3(2). Our CRISPR-Cas9 system successfully inactivated the targeted genes. When no templates for homology-directed repair (HDR) were present, the site-specific DNA double-strand breaks (DSBs) introduced by Cas9 were repaired through the error-prone nonhomologous end joining (NHEJ) pathway, resulting in a library of deletions with variable sizes around the targeted sequence. If templates for HDR were provided at the same time, precise deletions of the targeted gene were observed with near 100% frequency. Moreover, we developed a system to efficiently and reversibly control expression of target genes, deemed CRISPRi, based on a catalytically dead variant of Cas9 (dCas9). The CRISPR-Cas9 based system described here comprises a powerful and broadly applicable set of tools to manipulate actinomycetal genomes.
放线菌目细菌是药理活性和工业相关次级代谢产物的最重要来源之一。不幸的是,它们中的许多仍然难以进行基因操作,这是系统代谢工程的一个瓶颈。为了促进放线菌的基因操作,我们开发了一种高效的CRISPR-Cas9系统,用于在放线菌中删除基因或基因簇、进行精确的基因替换以及可逆地控制基因表达。我们通过靶向天蓝色链霉菌A3(2)中放线紫红素生物合成基因簇的两个基因actIORF1(SCO5087)和actVB(SCO5092)来展示我们的系统。我们的CRISPR-Cas9系统成功使靶向基因失活。当不存在同源定向修复(HDR)模板时,Cas9引入的位点特异性DNA双链断裂(DSB)通过易出错的非同源末端连接(NHEJ)途径进行修复,导致在靶向序列周围产生一系列大小可变的缺失文库。如果同时提供HDR模板,则观察到靶向基因的精确缺失频率接近100%。此外,我们基于Cas9的催化失活变体(dCas9)开发了一种系统,用于高效且可逆地控制靶基因的表达,称为CRISPRi。本文所述的基于CRISPR-Cas9的系统包含一套强大且广泛适用的工具,用于操纵放线菌基因组。